Benefits of the ketogenic diet (KD) in epileptic patients are well known while less is known about the nutritional risks of the diet and its potential impacts on biochemical nutritional status. In this study, we aimed to evaluate the hematological parameters of patients who have drug-resistant epilepsy and are treated with KD. Fifty-three patients with drug-resistant epilepsy (mean age 7.4 ± 4.4 years [2–18], 23 [43.4%] female) were included in the study. Demographic and laboratory data of the patients were retrospectively analyzed at baseline and Month 6 and Month 12 of the treatment. Repeated measures ANOVA (post hoc Bonferroni correction) and Friedman test were used to assess the changes in data during the treatment. Mean hemoglobin levels increased by 0.594 g/dL after 6 months (p = 0.001) and by 0.602 g/dL after 12 months of the treatment (p = 0.002). Mean hematocrit level was found to be significantly increased at Month 6 and 12 of the treatment compared to baseline [F(2,94) = 8.9, p < 0.0001]. An increase in MCV levels was determined with the KD treatment [F(2,94) = 19.7, p < 0.0001]. Mean level of vitamin B12 was found to be significantly increased in Month 12 of treatments compared to Month 6 [F(1.686,72.479) = 3.472, p = 0.035]. There was no significant effect of KD on other hematological parameters (red blood cell, white blood cell and platelet counts, serum iron, total iron-binding capacity, transferrin saturation, and ferritin and folic acid levels). We can conclude that KD increases levels of hemoglobin, hematocrit, MCV, and serum vitamin B12 in patients with intractable epilepsy. Prospective, multi-center, longitudinal studies are needed to confirm our results.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Wilder RM (1921) Effect of ketonuria on course of epilepsy. Mayo Clin Proc 2:307–308
Hemingway C, Freeman JM, Pillas DJ, Pyzik PL (2001) The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 108:898–905
Huttenlocher PR (1976) Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 10:536–540
Kose E, Guzel O, Demir K, Arslan N (2017) Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy. J Pediatr Endocrinol Metab 30:411–416
Arslan N, Guzel O, Kose E, Yılmaz U, Kuyum P, Aksoy B, Çalık T (2016) Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy? Seizure 43:32–38
Arslan N, Kose E, Guzel O (2016) The effect of ketogenic diet on serum selenium levels in patients with intractable epilepsy. Biol Trace Elem Res. https://doi.org/10.1007/s12011-016-0897-7
Güzel O, Yılmaz U, Uysal U, Arslan N (2016) The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 37:465–470
Couch SC, Schwarzman F, Carroll J, Koenigsberger D, Nordli DR, Deckelbaum RJ, DeFelice AR (1999) Growth and nutritional outcomes of children treated with the ketogenic diet. J Am Diet Assoc 99:1573–1575
Nazarewicz RR, Ziolkowski W, Vaccaro PS, Ghafourifar P (2007) Effect of short-term ketogenic diet on redox status of human blood. Rejuvenation Res 10:435–440
Liu YM, Williams S, Basualdo-Hammond C, Stephens D, Curtis R (2003) A prospective study: growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc 103:707–712
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077
Suo C, Liao J, Lu X, Fang K, Hu Y, Chen L, Cao D, Huang T, Li B, Li C (2013) Efficacy and safety of the ketogenic diet in Chinese children. Seizure 22:174–178
Kang HC, Chung DE, Kim DW, Kim HD (2004) Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 45:1116–1123
Volpe SL, Schall JI, Gallagher PR, Stallings VA, Bergqvist AG (2007) Nutrient intake of children with intractable epilepsy compared with healthy children. J Am Diet Assoc 107:1014–1018
Bertoli S, Cardinali S, Veggiotti P, Trentani C, Testolin G, Tagliabue A (2006) Evaluation of nutritional status in children with refractory epilepsy. Nutr J 5:14
Conflict of interest
The authors declare that they have no conflict of interest.
The study protocol was designed in compliance with the Declaration of Helsinki, 1964. Informed consent was obtained from the parents of participants during enrollment in the study. The study was initiated after the approval of the Ethics Committee of the Dokuz Eylul University Hospital (Date: 03.03.2016, number: 2016/06-01).
About this article
Cite this article
Kose, E., Guzel, O. & Arslan, N. Analysis of hematological parameters in patients treated with ketogenic diet due to drug-resistant epilepsy. Neurol Sci 39, 85–89 (2018). https://doi.org/10.1007/s10072-017-3152-x
- Folic acid
- Hematological parameters
- Ketogenic diet
- Vitamin B12